Fund shareholders of Adicet Bio Inc
ISIN US0070022076 · United States · LEI 549300VRD2QO80WBOP18
- Fund shareholders
- 14
- Of which ETFs
- 1 13 other funds
- Value held
- ≈ 4.7M $ 4.7M $ · 20.3K €
- Share of capital
- 7.0 % of 9.4M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 225,186 | 1.7M $ | 0.16 % | 2.41 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 213,118 | 1.5M $ | 0.00 % | 2.28 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 99,248 | 675.9K $ | 0.00 % | 1.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 48,143 | 349K $ | 0.00 % | 0.51 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 18,112 | 123.3K $ | 0.00 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 17,363 | 125.9K $ | 0.00 % | 0.19 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 11,188 | 81.1K $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 9,372 | 70.8K $ | 0.00 % | 0.10 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 6,046 | 41.2K $ | 0.00 % | 0.06 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 4,870 | 36.8K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 4,839 | 35.1K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1,489 | 10.1K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 269 | 1.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 20.3K € | 0.02 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.16 % | as of Apr 30, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.02 % | as of Dec 31, 2025 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 13 | +3 | 659,243 | +26.2 % |
| 2026Q1 | 10 | 522,305 |
Institutional managers
44 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 1,182,624 | 8.1M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 1,027,944 | 7M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 626,571 | 4.3M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 381,823 | 2.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 313,124 | 2.1M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 274,375 | 1.9M $ | as of Mar 31, 2026 |
| Prosight Management, LP | 250,244 | 1.7M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 232,591 | 1.6M $ | as of Mar 31, 2026 |
| Stonepine Capital Management, LLC | 221,955 | 1.5M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 203,799 | 1.4M $ | as of Mar 31, 2026 |
| Carlyle Group Inc. | 184,295 | 1.3M $ | as of Mar 31, 2026 |
| NEXTBio Capital Management LP | 157,827 | 1.1M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 118,138 | 802 $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 101,135 | 689K $ | as of Mar 31, 2026 |
| DAFNA Capital Management LLC | 93,812 | 638.9K $ | as of Mar 31, 2026 |
| Burkehill Global Management, LP | 62,500 | 425.6K $ | as of Mar 31, 2026 |
| Rangeley Capital, LLC | 56,000 | 381.4K $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 53,827 | 366.6K $ | as of Mar 31, 2026 |
| Trexquant Investment LP | 43,666 | 297.4K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 43,106 | 293.6K $ | as of Mar 31, 2026 |
| RBF Capital, LLC | 38,582 | 262.7K $ | as of Mar 31, 2026 |
| UBS Group AG | 38,368 | 261.3K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 37,084 | 252.5K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 36,585 | 249.1K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 36,222 | 246.7K $ | as of Mar 31, 2026 |
Declared shareholders of Adicet Bio Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RA Capital Management, L.P. and 3 others | 12.30 % | 1,182,624 | as of Feb 17, 2026 · SCHEDULE 13G |
| Woodline Partners LP | 3.30 % | 313,124 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Adicet Bio Inc". https://titelia.com/en/stocks/adicet-bio-inc-US0070022076